Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 2
1947 1
1948 2
1951 1
1952 2
1954 2
1955 1
1958 4
1959 2
1960 2
1961 3
1963 1
1964 4
1966 1
1968 3
1969 4
1970 3
1971 5
1973 2
1974 3
1975 5
1976 8
1977 7
1978 4
1979 11
1980 4
1981 7
1982 10
1983 12
1984 21
1985 18
1986 16
1987 14
1988 15
1989 17
1990 13
1991 17
1992 7
1993 6
1994 8
1995 15
1996 20
1997 19
1998 16
1999 12
2000 14
2001 14
2002 16
2003 10
2004 15
2005 14
2006 24
2007 26
2008 27
2009 26
2010 36
2011 44
2012 25
2013 47
2014 39
2015 33
2016 23
2017 48
2018 40
2019 69
2020 65
2021 61
2022 56
2023 46
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

1,080 results

Results by year

Filters applied: . Clear all
Page 1
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.
Hofman MS, Emmett L, Sandhu S, Iravani A, Joshua AM, Goh JC, Pattison DA, Tan TH, Kirkwood ID, Ng S, Francis RJ, Gedye C, Rutherford NK, Weickhardt A, Scott AM, Lee ST, Kwan EM, Azad AA, Ramdave S, Redfern AD, Macdonald W, Guminski A, Hsiao E, Chua W, Lin P, Zhang AY, McJannett MM, Stockler MR, Violet JA, Williams SG, Martin AJ, Davis ID; TheraP Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Hofman MS, et al. Among authors: francis rj. Lancet. 2021 Feb 27;397(10276):797-804. doi: 10.1016/S0140-6736(21)00237-3. Epub 2021 Feb 11. Lancet. 2021. PMID: 33581798 Clinical Trial.
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.
Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, Rutherford N, Martin JM, Frydenberg M, Shakher R, Wong LM, Taubman K, Ting Lee S, Hsiao E, Roach P, Nottage M, Kirkwood I, Hayne D, Link E, Marusic P, Matera A, Herschtal A, Iravani A, Hicks RJ, Williams S, Murphy DG; proPSMA Study Group Collaborators. Hofman MS, et al. Among authors: francis rj. Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22. Lancet. 2020. PMID: 32209449 Clinical Trial.
Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline.
Ralston SH, Corral-Gudino L, Cooper C, Francis RM, Fraser WD, Gennari L, Guañabens N, Javaid MK, Layfield R, O'Neill TW, Russell RGG, Stone MD, Simpson K, Wilkinson D, Wills R, Zillikens MC, Tuck SP. Ralston SH, et al. Among authors: francis rm. J Bone Miner Res. 2019 Apr;34(4):579-604. doi: 10.1002/jbmr.3657. Epub 2019 Feb 25. J Bone Miner Res. 2019. PMID: 30803025 Free PMC article. Review.
Sichere Kinderanästhesie – von der Evidenz zur Praxis!
Francis RCE, Spies C. Francis RCE, et al. Anasthesiol Intensivmed Notfallmed Schmerzther. 2018 Nov;53(11-12):738-740. doi: 10.1055/a-0750-2786. Epub 2018 Nov 20. Anasthesiol Intensivmed Notfallmed Schmerzther. 2018. PMID: 30458571 German. No abstract available.
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial.
Buteau JP, Martin AJ, Emmett L, Iravani A, Sandhu S, Joshua AM, Francis RJ, Zhang AY, Scott AM, Lee ST, Azad AA, McJannett MM, Stockler MR, Williams SG, Davis ID, Hofman MS; TheraP Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Buteau JP, et al. Among authors: francis rj. Lancet Oncol. 2022 Nov;23(11):1389-1397. doi: 10.1016/S1470-2045(22)00605-2. Epub 2022 Oct 16. Lancet Oncol. 2022. PMID: 36261050 Clinical Trial.
Association of Genetic and Environmental Factors With Autism in a 5-Country Cohort.
Bai D, Yip BHK, Windham GC, Sourander A, Francis R, Yoffe R, Glasson E, Mahjani B, Suominen A, Leonard H, Gissler M, Buxbaum JD, Wong K, Schendel D, Kodesh A, Breshnahan M, Levine SZ, Parner ET, Hansen SN, Hultman C, Reichenberg A, Sandin S. Bai D, et al. Among authors: francis r. JAMA Psychiatry. 2019 Oct 1;76(10):1035-1043. doi: 10.1001/jamapsychiatry.2019.1411. JAMA Psychiatry. 2019. PMID: 31314057 Free PMC article.
Recurrence Risk of Autism in Siblings and Cousins: A Multinational, Population-Based Study.
Hansen SN, Schendel DE, Francis RW, Windham GC, Bresnahan M, Levine SZ, Reichenberg A, Gissler M, Kodesh A, Bai D, Yip BHK, Leonard H, Sandin S, Buxbaum JD, Hultman C, Sourander A, Glasson EJ, Wong K, Öberg R, Parner ET. Hansen SN, et al. Among authors: francis rw. J Am Acad Child Adolesc Psychiatry. 2019 Sep;58(9):866-875. doi: 10.1016/j.jaac.2018.11.017. Epub 2019 Mar 6. J Am Acad Child Adolesc Psychiatry. 2019. PMID: 30851399 Free PMC article.
Robot assisted training for the upper limb after stroke (RATULS): a multicentre randomised controlled trial.
Rodgers H, Bosomworth H, Krebs HI, van Wijck F, Howel D, Wilson N, Aird L, Alvarado N, Andole S, Cohen DL, Dawson J, Fernandez-Garcia C, Finch T, Ford GA, Francis R, Hogg S, Hughes N, Price CI, Ternent L, Turner DL, Vale L, Wilkes S, Shaw L. Rodgers H, et al. Among authors: francis r. Lancet. 2019 Jul 6;394(10192):51-62. doi: 10.1016/S0140-6736(19)31055-4. Epub 2019 May 22. Lancet. 2019. PMID: 31128926 Free PMC article. Clinical Trial.
In memoriam: Warren M. Zapol.
Berra L, Falke KJ, Francis RCE, Roberts JD, Chiche JD. Berra L, et al. Among authors: francis rce. Intensive Care Med. 2022 Mar;48(3):383-385. doi: 10.1007/s00134-022-06622-3. Epub 2022 Jan 21. Intensive Care Med. 2022. PMID: 35061052 No abstract available.
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial.
Hofman MS, Emmett L, Sandhu S, Iravani A, Buteau JP, Joshua AM, Goh JC, Pattison DA, Tan TH, Kirkwood ID, Ng S, Francis RJ, Gedye C, Rutherford NK, Weickhardt A, Scott AM, Lee ST, Kwan EM, Azad AA, Ramdave S, Redfern AD, Macdonald W, Guminski A, Hsiao E, Chua W, Lin P, Zhang AY, Stockler MR, Williams SG, Martin AJ, Davis ID; TheraP Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Hofman MS, et al. Among authors: francis rj. Lancet Oncol. 2024 Jan;25(1):99-107. doi: 10.1016/S1470-2045(23)00529-6. Epub 2023 Nov 30. Lancet Oncol. 2024. PMID: 38043558 Clinical Trial.
1,080 results